A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLCVanita Noronha,Nandini S. Menon,Vijay Maruti Patil,M. V. Chandrakanth,Sucheta More,Aditya Dhanawat, Oindrila Roy Chowdhary,Ajaykumar Chandrabhan Singh,Supriya Goud,Srushti Shah,Naveen Karuvandan,Kunal Naishadh Jobanputra, Darshit Kalpeshkumar,Minit Jalan Shah, Rupjyoti Sarma, Dhwaniben Patel,Ritam Joarder,Prashant Kumar,Anupa John,Jaspreet Kaur, Saurabh Bagra,Nilendu Purandare,Amit Janu,Abhishek Mahajan,Kumar PrabhashJTO CLINICAL AND RESEARCH REPORTS(2024)引用 4|浏览20关键词Third line,Non–small cell lung cancer,EGFR TKI,ChemotherapyAI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要